
WS Investments
Description
WS Investment Co. is the venerable investment fund of the prominent law firm Wilson Sonsini Goodrich & Rosati (WSGR), established in 1978. This makes it one of the longest-standing law firm-affiliated investment vehicles in the venture capital ecosystem. The fund was created with the unique purpose of aligning interests with WSGR's clients by co-investing alongside them, primarily in early-stage financing rounds. This strategic approach provides not only capital but also deep insights into the legal and business challenges faced by emerging companies, leveraging the firm's extensive network and expertise.
The core of WS Investment Co.'s strategy revolves around participating in rounds where WSGR serves as legal counsel, fostering a symbiotic relationship between legal services and financial backing. They typically engage in seed, Series A, and occasionally Series B rounds, focusing on sectors that align with WSGR's strong practice areas, such as technology, life sciences, and clean energy. Their role is often that of a strategic co-investor rather than a lead investor, complementing larger venture capital firms.
WS Investment Co. typically deploys first cheques ranging from approximately $50,000 to $500,000, reflecting their role as a participant rather than a primary capital provider in larger rounds. Over its decades of operation, the fund has invested in thousands of companies, contributing to the growth of numerous successful enterprises that have gone on to become industry leaders. This long-term commitment and unique model underscore its significant, albeit often understated, influence within the venture capital landscape, particularly in Silicon Valley.
Investor Profile
WS Investments has backed more than 54 startups, with 0 new investments in the last 12 months alone. The firm has led 6 rounds, about 11% of its total and boasts 19 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series B rounds (top funding stages).
- Majority of deals are located in United States, Australia.
- Strong thematic focus on Health Care, Software, Biotechnology.
- Typical check size: $50K – $500K.
Stage Focus
- Seed (28%)
- Series A (26%)
- Series B (15%)
- Series Unknown (9%)
- Series C (6%)
- Series D (4%)
- Series E (4%)
- Pre Seed (4%)
- Series F (2%)
- Post Ipo Equity (2%)
Country Focus
- United States (98%)
- Australia (2%)
Industry Focus
- Health Care
- Software
- Biotechnology
- Medical
- Therapeutics
- Enterprise Software
- Health Diagnostics
- E-commerce
- Tv
- Computer
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.